Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Rev J Autism Dev Disord ; : 1-31, 2021 Jul 16.
Article in English | MEDLINE | ID: covidwho-2256594

ABSTRACT

As the need for accessible interventions for autism spectrum disorder (ASD) grows, empirically supported telehealth interventions become increasingly necessary. With the current COVID-19 public health crisis, in-person interventions have become largely infeasible; therefore, it is crucial that providers have information regarding the effectiveness of telehealth interventions. This systematic review evaluates and synthesizes existing group design research on telehealth ASD interventions. Sixteen articles were evaluated on implementer and child-level intervention outcomes as well as factors that promote equitable access to intervention. Findings suggest that telehealth programs are highly acceptable, comparable to face-to-face interventions, and can be an effective method of training implementers in interventions. Recommendations for future research and for maximizing equitable access to telehealth interventions are presented.

2.
J Autism Dev Disord ; 52(12): 5383-5394, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-1588769

ABSTRACT

Interest in telehealth assessment for autism has increased due to COVID-19 and subsequent expansion of remote psychological services, though options that are easy for clinicians to adopt and available through the lifespan are limited. The Brief Observation of Symptoms of Autism (BOSA) provides a social context with standardized materials and activities that can be coded by clinicians trained in the Autism Diagnostic Observation Schedule. The current project examined psychometric properties to determine optimal use for each BOSA version. Three hundred and seven participants with 453 BOSAs were included to determine best performing items for algorithms, validity, sensitivity, specificity, recommended cut-offs, and proposed ranges of concern. While preliminary, the BOSA provides a promising new option for telehealth-administered assessment for autism.


Subject(s)
Autism Spectrum Disorder , Autistic Disorder , COVID-19 , Telemedicine , Humans , Autistic Disorder/diagnosis , Autistic Disorder/psychology , Autism Spectrum Disorder/diagnosis , Autism Spectrum Disorder/psychology , Reproducibility of Results
SELECTION OF CITATIONS
SEARCH DETAIL